
Marianne P. Allen
Examiner (ID: 17617, Phone: (571)272-0712 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1818, 1812, 1645, 1805, 1631, 1647 |
| Total Applications | 2168 |
| Issued Applications | 1046 |
| Pending Applications | 251 |
| Abandoned Applications | 885 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5409571
[patent_doc_number] => 20090123469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Anti-factor B antibodies and their uses'
[patent_app_type] => utility
[patent_app_number] => 12/291222
[patent_app_country] => US
[patent_app_date] => 2008-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17601
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123469.pdf
[firstpage_image] =>[orig_patent_app_number] => 12291222
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/291222 | Anti-factor B antibodies and their uses | Nov 5, 2008 | Issued |
Array
(
[id] => 5533047
[patent_doc_number] => 20090232835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Composition for delivery of hematopoietic growth factor'
[patent_app_type] => utility
[patent_app_number] => 12/291344
[patent_app_country] => US
[patent_app_date] => 2008-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9556
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232835.pdf
[firstpage_image] =>[orig_patent_app_number] => 12291344
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/291344 | Composition for delivery of hematopoietic growth factor | Nov 5, 2008 | Abandoned |
Array
(
[id] => 5422488
[patent_doc_number] => 20090148943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'AGENT FOR ENHANCING THE PRODUCTION OF CYTOKINES AND/OR CHEMOKINES'
[patent_app_type] => utility
[patent_app_number] => 12/265348
[patent_app_country] => US
[patent_app_date] => 2008-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8658
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20090148943.pdf
[firstpage_image] =>[orig_patent_app_number] => 12265348
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/265348 | AGENT FOR ENHANCING THE PRODUCTION OF CYTOKINES AND/OR CHEMOKINES | Nov 4, 2008 | Abandoned |
Array
(
[id] => 9020633
[patent_doc_number] => 08530619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-10
[patent_title] => 'Identification of the hepcidin binding site on ferroportin'
[patent_app_type] => utility
[patent_app_number] => 12/734061
[patent_app_country] => US
[patent_app_date] => 2008-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 24
[patent_no_of_words] => 10043
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12734061
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/734061 | Identification of the hepcidin binding site on ferroportin | Oct 26, 2008 | Issued |
Array
(
[id] => 6196928
[patent_doc_number] => 20110028686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'Protein binding miniature proteins'
[patent_app_type] => utility
[patent_app_number] => 12/288401
[patent_app_country] => US
[patent_app_date] => 2008-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 37458
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20110028686.pdf
[firstpage_image] =>[orig_patent_app_number] => 12288401
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/288401 | Protein binding miniature proteins | Oct 19, 2008 | Abandoned |
Array
(
[id] => 6615317
[patent_doc_number] => 20100310548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'Methods of Manufacturing a Biologic Using a Stable Storage Intermediate'
[patent_app_type] => utility
[patent_app_number] => 12/738091
[patent_app_country] => US
[patent_app_date] => 2008-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19089
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0310/20100310548.pdf
[firstpage_image] =>[orig_patent_app_number] => 12738091
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/738091 | Methods of Manufacturing a Biologic Using a Stable Storage Intermediate | Oct 14, 2008 | Abandoned |
Array
(
[id] => 6266498
[patent_doc_number] => 20100298236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'SOLUBLE GP130 MUTEINS WITH IMPROVED BINDING ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/738807
[patent_app_country] => US
[patent_app_date] => 2008-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9444
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298236.pdf
[firstpage_image] =>[orig_patent_app_number] => 12738807
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/738807 | Soluble GP130 muteins with improved binding activity | Oct 14, 2008 | Issued |
Array
(
[id] => 5380240
[patent_doc_number] => 20090192079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'PROLONGED DELIVERY OF HEPARIN-BINDING GROWTH FACTORS FROM HEPARIN-DERIVATIZED COLLAGEN'
[patent_app_type] => utility
[patent_app_number] => 12/248307
[patent_app_country] => US
[patent_app_date] => 2008-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6081
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20090192079.pdf
[firstpage_image] =>[orig_patent_app_number] => 12248307
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/248307 | PROLONGED DELIVERY OF HEPARIN-BINDING GROWTH FACTORS FROM HEPARIN-DERIVATIZED COLLAGEN | Oct 8, 2008 | Abandoned |
Array
(
[id] => 6054596
[patent_doc_number] => 20110110956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding Proteins'
[patent_app_type] => utility
[patent_app_number] => 12/680191
[patent_app_country] => US
[patent_app_date] => 2008-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 233
[patent_figures_cnt] => 233
[patent_no_of_words] => 53240
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20110110956.pdf
[firstpage_image] =>[orig_patent_app_number] => 12680191
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/680191 | Heparin-binding epidermal growth factor-like growth factor binding proteins | Sep 25, 2008 | Issued |
Array
(
[id] => 5429163
[patent_doc_number] => 20090088473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'METHOD FOR SCREENING OF PROSTAGLANDIN COMPOUNDS COMPRISING AN OPTIMAL FORMULATION FOR THE ENHANCEMENT OF HAIR GROWTH AND THE STIMULATION OF FOLLICULAR ANAGEN AND FORMULATIONS RESULTING THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 12/239237
[patent_app_country] => US
[patent_app_date] => 2008-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1900
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20090088473.pdf
[firstpage_image] =>[orig_patent_app_number] => 12239237
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/239237 | METHOD FOR SCREENING OF PROSTAGLANDIN COMPOUNDS COMPRISING AN OPTIMAL FORMULATION FOR THE ENHANCEMENT OF HAIR GROWTH AND THE STIMULATION OF FOLLICULAR ANAGEN AND FORMULATIONS RESULTING THEREFROM | Sep 25, 2008 | Abandoned |
Array
(
[id] => 6506258
[patent_doc_number] => 20100210520
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2010-08-19
[patent_title] => 'REGULATION OF FUNCTION OF ANGIOPOIETIN'
[patent_app_type] => utility
[patent_app_number] => 12/211073
[patent_app_country] => US
[patent_app_date] => 2008-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15090
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0210/20100210520.pdf
[firstpage_image] =>[orig_patent_app_number] => 12211073
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/211073 | REGULATION OF FUNCTION OF ANGIOPOIETIN | Sep 14, 2008 | Abandoned |
Array
(
[id] => 6506258
[patent_doc_number] => 20100210520
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2010-08-19
[patent_title] => 'REGULATION OF FUNCTION OF ANGIOPOIETIN'
[patent_app_type] => utility
[patent_app_number] => 12/211073
[patent_app_country] => US
[patent_app_date] => 2008-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15090
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0210/20100210520.pdf
[firstpage_image] =>[orig_patent_app_number] => 12211073
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/211073 | REGULATION OF FUNCTION OF ANGIOPOIETIN | Sep 14, 2008 | Abandoned |
Array
(
[id] => 6070670
[patent_doc_number] => 20110045520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'FATTY ACID MARKERS FOR THE DIAGNOSIS, PROGNOSIS AND MANAGEMENT OF CARDIOVASCULAR DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/674765
[patent_app_country] => US
[patent_app_date] => 2008-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7600
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20110045520.pdf
[firstpage_image] =>[orig_patent_app_number] => 12674765
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/674765 | FATTY ACID MARKERS FOR THE DIAGNOSIS, PROGNOSIS AND MANAGEMENT OF CARDIOVASCULAR DISEASE | Sep 11, 2008 | Abandoned |
Array
(
[id] => 5279197
[patent_doc_number] => 20090131329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Treatment for allograft rejection'
[patent_app_type] => utility
[patent_app_number] => 12/283246
[patent_app_country] => US
[patent_app_date] => 2008-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6280
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20090131329.pdf
[firstpage_image] =>[orig_patent_app_number] => 12283246
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/283246 | Treatment for allograft rejection | Sep 9, 2008 | Abandoned |
Array
(
[id] => 6349236
[patent_doc_number] => 20100249019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'USE OF A PEPTIDE AS A THERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/677805
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36441
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20100249019.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677805
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677805 | USE OF A PEPTIDE AS A THERAPEUTIC AGENT | Sep 8, 2008 | Abandoned |
Array
(
[id] => 6231574
[patent_doc_number] => 20100184708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'USE OF GLY-PRO-GLU-OH (GPE) AS A THERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/677812
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33413
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184708.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677812
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677812 | USE OF GLY-PRO-GLU-OH (GPE) AS A THERAPEUTIC AGENT | Sep 8, 2008 | Abandoned |
Array
(
[id] => 4759913
[patent_doc_number] => 20080312139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Use of Pharmaceutical Composition Containing Epidermal Growth Factor (EGF) for Diabetic foot Amputation Prevention'
[patent_app_type] => utility
[patent_app_number] => 12/197001
[patent_app_country] => US
[patent_app_date] => 2008-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4382
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312139.pdf
[firstpage_image] =>[orig_patent_app_number] => 12197001
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/197001 | Use of pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention | Aug 21, 2008 | Issued |
Array
(
[id] => 5297340
[patent_doc_number] => 20090012266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Anti-TNFalpha Antibodies and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 12/189237
[patent_app_country] => US
[patent_app_date] => 2008-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5157
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012266.pdf
[firstpage_image] =>[orig_patent_app_number] => 12189237
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/189237 | Anti-TNFα antibodies and methods of use | Aug 10, 2008 | Issued |
Array
(
[id] => 5496342
[patent_doc_number] => 20090264370
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2009-10-22
[patent_title] => 'POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1'
[patent_app_type] => utility
[patent_app_number] => 12/189012
[patent_app_country] => US
[patent_app_date] => 2008-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 38459
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0264/20090264370.pdf
[firstpage_image] =>[orig_patent_app_number] => 12189012
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/189012 | POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1 | Aug 7, 2008 | Abandoned |
Array
(
[id] => 5496342
[patent_doc_number] => 20090264370
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2009-10-22
[patent_title] => 'POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1'
[patent_app_type] => utility
[patent_app_number] => 12/189012
[patent_app_country] => US
[patent_app_date] => 2008-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 38459
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0264/20090264370.pdf
[firstpage_image] =>[orig_patent_app_number] => 12189012
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/189012 | POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1 | Aug 7, 2008 | Abandoned |